Toho Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 2024
November 09, 2023 at 11:00 pm EST
Share
Toho Holdings Co., Ltd. provided consolidated earnings guidance for the full year ending March 2024. For the period, the company expects net sales of JPY 1,325,000 million, operating profit of JPY 11,500 million, profit attributable to owners of parent of JPY 12,300 million and basic earnings per share of JPY 190.65.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
TOHO HOLDINGS CO., LTD. 
